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Abstract
Recent studies have revealed a remarkable molecular diversity of Plasmodium parasites in great apes in Africa, as well as parasite
exchange events between these primates and humans. We review the different points of view proposed on the origin of human malaria,
and discuss ape Plasmodium parasites as a source of human outbreaks.
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Introduction
In the middle of the twentieth century, numerous experi-
mental malarial infections were induced in humans (either by
mosquito bites or by direct blood transfusion) to test the
potential zoonotic character of malarial pathogens isolated
from wild-living African chimpanzees and gorillas, and Asian
non-human primates [1]. The ability of a species to infect
humans in laboratory conditions is summarized in Table 1. It
is worth noting that only a few species, all primates originat-
ing from Southeast Asia, were considered to be able to
infect humans [1].
Today, molecular tools allow exploration of the diversity
of wildlife haemosporidian parasites (i.e. the genera Plasmo-
dium, Hepatocystis, etc.) [2–5]. Data collected in recent years
have shown notable Plasmodium diversity in non-human pri-
mates, especially in African great apes [6,7]. Considering the
current overall molecular phylogeny of haemosporidian para-
sites, it appears that human Plasmodium species are polyphy-
letic (Fig. 1) [8]. Thus, multiple switches between mammalian
hosts are likely to explain the evolutionary history of human
malarias [8,9]. As shown in mammalian hosts, host switches
appear to be common phenomena in the evolution of malar-
ial parasites [10–12].
On the basis of recent data included in the growing litera-
ture on this topic, we present here different hypotheses on
malarial spread in human populations, and discuss the poten-
tial risk of ongoing or future outbreaks of ape malarial para-
sites in humans.
Non-Laverania Plasmodium
Before the successful eradication campaigns in the middle of
the twentieth century, Plasmodium vivax, found as far as north-
ern Europe, was the malarial parasite with the broadest geo-
graphical coverage [13]. Its impact on human health has been
indirectly demonstrated by traces of selective pressures on
the human genome, particularly on the Duffy blood group in
African human populations and glucose-6-phosphate dehydro-
genase deﬁciency in Asia [14,15]. P. vivax belongs to the mono-
phyletic group of Plasmodium parasites infecting catarrhine
monkeys in Southeast Asia [8,16]. It is generally accepted that
it originated in humans as a consequence of host capture from
macaques to hominids in Southeast Asia [17,18].
Interestingly, despite numerous studies on Plasmodium par-
asites infecting Southeast Asian primates (including the
orangutan, the Asian great ape), none of them was found to
be infected with P. vivax [19]. On the other hand, captive
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and wild-living African gorillas and chimpanzees were
recently found to be infected with a Plasmodium parasite with
mitochondrial DNA similar to that of human P. vivax
[7,20,21]. In 2003, Carter argued that ‘P.vivax would have
been isolated in human African populations during the late
ice age between 100 000 and 20 000 years ago’ [22]. If this
is the case, the P. vivax population currently observed in
great apes could be the descendants of this ancient P. vivax
lineage, which led to red blood cell (RBC) Duffy-negative
selection in African human populations. Thus, the P. vivax
cases described in non-African people returning from Africa
might result from zoonotic ape transmission [23].
However, serological studies have demonstrated an
immune response speciﬁc to P. vivax in West Central African
populations, and molecular diagnosis evidence has conﬁrmed
the possibility of such infections in Duffy antigen-negative
humans [24–26]. This strongly suggests that P. vivax exploits
an alternative pathway to invade Duffy-negative RBCs. This
stresses the need to determine the epidemiology of P. vivax
throughout Africa and evaluate the capacity of new Duffy-
independent P. vivax strains to emerge. Comparative surveys
need to be performed in ape populations to evaluate their
possible involvement in the emergence and spread of P. vivax
in Africa.
Plasmodium knowlesi, transmitted by the Anopheles leucos-
phyrus group, is a parasite that naturally infects primates
belonging to the genus Macaca in Southeast Asia [1]. For the
past 10 years, the increasing systematic use of relevant
molecular malaria diagnosis has highlighted an impressive
number of unsuspected human P. knowlesi infections. The
ﬁrst cases were detected in Malaysia and the Philippines
[27,28]. Today, P. knowlesi is found infecting Thai, Vietnamese
and Cambodian populations, for whom environmental
anthropization overlaps with the natural geographical distri-
bution of macaques [29–31]. Modiﬁcations of the wildlife
population biogeography might favour close interactions and
parasite exchanges. The question remains: is P. knowlesi
spreading over Southeast Asia via interhuman exchanges as a
new human outbreak, or only via macaques to human host
switches? Furthermore, have these new human P. knowlesi
infections originated recently, or are they simply more read-
ily detected by molecular tools [32–34]? In Cambodia, it
seems that the presence of this species in the human popula-
tion is recent, and no macaques have yet been found to be
infected with P. knowlesi [31]. This could argue for possible
interhuman transmission. Considering that P. knowlesi has
been responsible for fatal cases [35], and the possibility of
P. knowlesi being transmitted by Anopheles stephensi, a wide-
spread vector in Asia, particularly in the Indian subcontinent,
this parasite is a serious candidate for a potential human out-
break [36–38]. It is paticularly urgent to implement contain-
ment and monitoring measures, in order to better
characterize the transmission of this species to humans and
propose appropriate control measures.
Plasmodium schwetzi, which is morphologically similar to
human Plasmodium ovale (or P. vivax), was originally described
by Reichenow in 1920 in apes from Cameroon [1]. Experi-
mental infections by P. schwetzi in humans have been
reported [39], and in 1970 Contacos established its zoonotic
potential in Africa [40]. Plasmodium rodhaini, another African
great ape Plasmodium species, which is morphologically simi-
lar to human Plasmodium malariae, was considered to be an
‘anthroponosis’ or a ‘zoonosis of long standing’ [1]. On the
basis of molecular data, it appears that chimpanzees can be
infected with human P. ovale and P. malariae and maintain
parasite infection for long periods [21,41,42]. They could
P. vivax group 
P. reichenowi
P. ovale group 
P. malagasy
P. vinkeia group 
Hepatocystis group 
P. falciparum
P. praefalciparum 
P. billcollinsi 
P. blacklocki 
P. gaboni 
P. alderi
P. cynomolgi
P. hilobati
P. knowlesi
P. gonderi
P. malariae group
Humans/African apes
Asian monkeys
Asian monkeys
Humans/Asian monkeys
African monkeys
Humans/African apes
Humans/African apes
Malagasy lemurs
African rodents
African/Asian mammals
Chimpanzees
Chimpanzees
Gorillas
Chimpanzees
Gorillas
Humans/African apes
Gorillas
Laverania
N
on-Laverania
*
*
*
*
FIG. 1. Schematic phylogeny of mammal Plasmodium parasites, show-
ing the polyphyly of human malarial parasites (in red). *Unresolved
nodes.
TABLE 1. Major Plasmodium species infecting primates, and
their ability to infect humans [1]
Species Natural host Origin
Infection
in humans
P. cynomolgi Macaca species Southeast Asia Yes
P. eylesi Gibbon Southeast Asia No
P. gonderi Cercocebus species Africa No
P. hylobati Gibbon Southeast Asia No
P. jefferyi Gibbon Southeast Asia No
P. pitheci Orangutan Southeast Asia ?
P. inui Macaca species Southeast Asia Yes
P. coatneyi Macaca species Southeast Asia No
P. knowlesi Macaca species Southeast Asia Yes
P. reichnowi Chimpanzee Africa No
P. girardi Lemur Madagascar ?
P. ﬁeldi Macaca species Southeast Asia No
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contribute to continuous parasite exchanges of these two
human malarial parasites in Africa. Furthermore, chimpanzees
harbour a larger diversity of P. ovale-like and P. malariae-like
parasites than humans [7,21,41]. A phylogeny inferred from
mitochondrial molecular data points to a recent common
ancestor of human P. ovale and P. malariae and those infecting
chimpanzees. However, no related parasites have been found
in gorilla hosts.
Laverania Plasmodium
Recent studies have revealed an unsuspected but remarkable
molecular diversity of Laverania parasites in captive and wild-
living great apes (gorillas, chimpanzees, and bonobos) in
West and Central Africa [6,7,20,43–45]. Most of these
studies, which signiﬁcantly increased our knowledge of
Plasmodium infections in wild apes, were based on new, non-
invasive malarial parasite detection in faecal samples, allowing
large-scale screening. On the basis of molecular, genetic and
phylogenetic characteristics, Laverania parasites seemed to
be, at this time, composed of at least six well-deﬁned, closely
related and host-speciﬁc clades. Rayner et al. [46] proposed
for clarity that these six Laverania clades could correspond
to six distinct ape Laverania species, named, respectively, Plas-
modium reichenowi, Plasmodium gaboni and Plasmodium billcollin-
si for chimpanzees (Pan troglodytes verus, Pan troglodytes ellioti,
Pan troglodytes troglodytes, and Pan troglodytes schweinfurthii)
and Plasmodium falciparum–Plasmodium praefalciparum, Plasmo-
dium adleri and Plasmodium blacklocki for malaria parasites
speciﬁc to gorillas (Gorilla gorilla). These malarial species
seem to be widely distributed in wild-living African ape popu-
lations, without geographical distinction, and with relatively
high prevalence, as observed for P. falciparum infections in
humans.
Phylogeny inferred from mitochondrial Laverania parasite
sequences revealed that parasitic exchange events between
great apes and humans have occurred during their evolution-
ary history, leading to the divergence of P. falciparum in
humans from that in gorillas [7,46], and making P. falciparum
an ancient outbreak in humans [47–49]. More recently, a
strain similar to P. falciparum has been reported in an African
pet monkey (Cercopithecus nictitans) [50], and the authors
argued that this ﬁnding challenged the gorilla origin of the
human P. falciparum parasite (i.e. African non-ape primate
origin). Unfortunately, this ﬁnding has been controversial,
being not well enough supported by the data [51]. These
potential host switches highlight, rather, a signiﬁcant adaptive
capacity of Laverania parasites to adapt to new, non-natural
hosts.
Until recently, it was assumed that P. falciparum and P. rei-
chenowi (the only close relative of P. falciparum known and
molecularly characterized) had evolved from a common
ancestor parasite, independently in their respective hosts,
humans and chimpanzees, as these two lineages have gradu-
ally diverged from one another over the last 5–7 million
years, i.e. the co-speciation hypothesis. The new ﬁndings on
malarial parasites in apes challenged this initial co-speciation
hypothesis, suggesting an alternative hypothesis for the origin
of the malignant human malarial parasite, i.e. a gorilla origin
of human P. falciparum. On the basis of comparison of mito-
chondrial DNA sequences from human P. falciparum strains
and malarial parasites closely related to human P. falciparum
strains in gorillas, Baron et al. [47] subsequently revised the
age estimates of P. falciparum infection in humans to between
1 million and 112 000 years.
Currently, P. falciparum appears to be the only Laverania
parasite that is able to infect humans; experimental infections
with P. reichenowi in humans have failed [1]. The invasion
of RBCs by P. reichenowi and P. falciparum depends mostly
on the interaction of erythrocyte-binding antigen -175 on
malarial merozoites with glycophorins, which are sialic
acid-containing glycoproteins on the surfaces of RBCs
(Fig. 2). N-Glycolylneuraminic acid is a sialic acid expressed
in apes and absent in human tissues, because of inactivation
of the gene encoding CMP-N-acetylneuraminic acid hydroxy-
lase [52,53]. Human DNA contains a 92-bp deletion, result-
ing in a frameshift mutation that prevents the production of
N-glycolylneuraminic acid, and that leads to the accumulation
of its precursor, N-acetylneuraminic acid (Neu5Ac). Both
molecular and fossil explorations (Neanderthals did not have
the enzyme needed to convert Neu5Ac) are congruent in
indicating the time of appearance of this mutation to be
around 2 million years ago [54]. It is hypothesized that Lavar-
ania malaria could be the main selective pressure resulting in
the ﬁxation of this allele in the entire human population. A
new Laverania parasite, able to use Neu5Ac to invade RBCs,
is supposed to have emerged in human populations, leading
to the well-known P. falciparum pathogen. The loss of
hydroxylase activity induced by Laverania malarial parasites
and the Duffy-negative antigen in African populations due to
P. vivax selective pressure highlight the ongoing interactions
between malarial parasites and humans during their evolu-
tionary history.
Large-scale sampling of wide-ranging African apes identi-
ﬁed only P. falciparum-like parasites in western lowland goril-
las [7]. In contrast, captive chimpanzees, living in close
proximity to human populations, have been found to be
infected with P. falciparum, highlighting their potential role as
a reservoir for P. falciparum or the fact that they could be
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victims of anthroponosis [45]. In addition to chimpanzees,
captive bonobos can also be infected with human P. falcipa-
rum strains (resistant to antimalarial drugs) [20]. The ques-
tion arises of the forces that drive Laverania parasites and
other Plasmodium parasites to be conﬁned to a speciﬁc host
or confer their ability to jump the species barrier and adapt
to another host [55]. Captive chimpanzees living in African
sanctuaries could represent a helpful model with which to
better understand host–parasite interactions, potential
human–ape and ape–ape parasite exchanges, and parasite
adaptation capacities. The hypothesis of a human malarial
parasite reservoir in apes could be tested, as well as the
pathogenicity of human malarial parasites and other Laverania
parasites in great apes. This would be extremely relevant for
malaria eradication programmes and ape conservation pro-
grammes [56]. Furthermore, the investigation of human pop-
ulations sharing the same environmental constraints as
chimpanzees and gorillas in nature with adequate molecular
diagnostic tools is paramount to document potential cases of
human malarial infections with ape malarial parasites.
Conclusions
Malaria is a well-known evolutionary force within the human
genome [57]. For P. vivax and P. falciparum, which are both
major public health concerns, there is convincing evidence of
an origin from a parasite host exchange from non-human pri-
mates to humans. Now, the new capacity of P. vivax to
invade Duffy-negative population needs to be conﬁrmed and
characterized across Africa. Also, the potential interhuman
transmission of P. knowlesi in Southeast Asia has to be evalu-
ated, in order for appropriate measures to be implemented.
In Central Africa, the close contact between apes and
humans, associated with the low level of control and monitor-
ing of malaria in remote areas, could represent a risk and stim-
ulate the emergence of another Laverania malarial parasite.
The ﬁrst priority is to enlarge surveys in this area, with ade-
quate molecular diagnostic tools. Documenting the potential
role of great apes and other non-human primates as reservoirs
for human malarial parasites, and their capacity to harbour
Plasmodium species able to switch to human populations, is
important for future malarial eradication programmes.
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